Arno Therapeutics, Inc — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/67f420ef-2ea5-4b65-b4f2-d954eb42f58e/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-11.5M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-091477 |
| FY 2014 | $7.8M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-020148 |
| FY 2013 | $-90.0M | 2005-08-01 – 2014-03-31 | evidence 0001144204-14-031220 |
| FY 2012 | $-50.8M | 2005-08-01 – 2013-03-31 | evidence 0001144204-13-029410 |
| FY 2011 | $-38.1M | 2005-08-01 – 2012-03-31 | evidence 0001144204-12-029411 |
| FY 2010 | $-27.6M | 2005-08-01 – 2010-12-31 | evidence 0001144204-14-031220 |
| FY 2009 | $-6.9M | 2009-01-01 – 2009-12-31 | evidence 0001144204-11-046663 |
| FY 2008 | $-12.9M | 2008-01-01 – 2008-12-31 | evidence 0001144204-11-046663 |
| FY 2007 | $-3.4M | 2007-01-01 – 2007-12-31 | evidence 0001144204-11-046663 |
| FY 2006 | $-370.9k | 2006-01-01 – 2006-12-31 | evidence 0001144204-14-019511 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).